Hosted on MSN1mon
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the WorldBut CML can become resistant to these therapies ... Last June, Ascentage granted Takeda Pharmaceuticals International an exclusive option to license olverembatinib for development and ...
Harrington Prize for Innovation in Medicine has been awarded to Owen N. Witte, MD, Distinguished University Professor and President's Chair in Developmental Immunology, David Geffen School of Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results